Xeroderma pigmentosum--bridging a gap between clinic and laboratory

Area of Science:

• Genetics
• Molecular Biology
• Dermatology

Background:

• Xeroderma pigmentosum (XP) is an autosomal recessive disorder characterized by extreme photosensitivity and a high incidence of UV-induced skin cancers.
• This condition stems from impaired DNA repair mechanisms, specifically nucleotide excision repair (NER).
• XP presents with diverse clinical manifestations, including neurological complications in certain complementation groups (XPA, B, D, G).

Purpose of the Study:

• To review the diagnosis, pathogenesis, and clinical management of Xeroderma pigmentosum (XP).
• To highlight advancements in molecular diagnostic techniques for XP.
• To discuss current therapeutic strategies and ongoing research for XP.

Main Methods:

• Laboratory diagnosis traditionally involved autoradiography.
• Recent advances include molecular techniques like polymerase chain reaction (PCR) and plasmid host cell reactivation assays.
• These methods facilitate diagnosis, carrier detection, and prenatal diagnosis, particularly for Japanese XPA patients.

Main Results:

• Molecular techniques have significantly improved the accuracy and accessibility of XP diagnosis.
• Understanding of DNA repair pathways (transcription-coupled repair and global genome repair) is crucial for XP pathogenesis.
• Clinical management emphasizes rigorous sun protection and explores therapeutic options like retinoids and interferon.

Conclusions:

• Early diagnosis and strict sun avoidance are paramount in managing XP.
• Molecular diagnostics offer powerful tools for genetic counseling and family planning in XP.
• While no cure exists, ongoing research into DNA repair and therapeutic interventions offers hope for improved patient outcomes.